Efficacy and safety of entinostat (ENT) and pembrolizumab (PEMBRO) in patients with non-small cell lung cancer (NSCLC) previously treated with anti-PD-(L) 1 therapy Meeting Abstract
| Authors: | Gandhi, L.; Janne, P. A.; Opyrchal, M.; Ramalingam, S. S.; Rybkin, I. I.; Hafez, N.; Raez, L. E.; Gabrilovich, D.; Wang, F.; Ordentlich, P.; Brouwer, S.; Sankoh, S.; Schmidt, E. V.; Meyers, M. L.; Hellmann, M. D. |
| Abstract Title: | Efficacy and safety of entinostat (ENT) and pembrolizumab (PEMBRO) in patients with non-small cell lung cancer (NSCLC) previously treated with anti-PD-(L) 1 therapy |
| Meeting Title: | 54th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 36 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2018 Jun 1-5 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2018-05-20 |
| Start Page: | 469s |
| Language: | English |
| ACCESSION: | WOS:000442916003210 |
| DOI: | 10.1200/JCO.2018.36.15_suppl.9036 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 9036 -- Source: Wos |
